middle.news
Viatris completes Pacira deal and expands non-opioid pain portfolio
1:44am on Wednesday 18th of November, 2026 AEDT
•
Pharmaceuticals
Read Story
Viatris completes Pacira deal and expands non-opioid pain portfolio
1:44am on Wednesday 18th of November, 2026 AEDT
Key Points
US$1.69 billion acquisition completed with cash and short-term borrowings
66.46% of Pacira shares were validly tendered
Pacira becomes a wholly owned Viatris subsidiary
US$90 million to US$100 million expected 2026 revenue contribution
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Viatris (NASDAQ:VTRS)
OPEN ARTICLE